Aims and Scope of Journal of Comparative Effectiveness Research
The Journal of Comparative Effectiveness Research is a peer-reviewed medical journal that was established in 2012 and is published by Future Medicine. The editors-in-chief are Sheldon Greenfield (University of California, Irvine) and Eugene Rich (Mathematica Policy Research). The journal covers all aspects of comparative effectiveness research, including patient-centered outcomes research, pharmacoeconomics and health economics, relating to diagnostics, therapeutics, surgical procedures, or other healthcare services or options. Less
Key Metrics
CiteScore 

2.8
H-Index 

30
Impact Factor 

< 5
SJR 

Q2Health Policy

SNIP 

0.71
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Comparative Effectiveness Research
Journal of Comparative Effectiveness Research Journal Specifications
Indexed in the following public directories
Web of Science
DOAJ
SJR
| Overview | |
| Publisher | BECARIS PUBLISHING |
| Language | English |
| Frequency | Semi-monthly |
| Article Processing Charges | USD 3500 |
| Publication Time | 14 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Journal of Comparative Effectiveness Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Comparative Effectiveness Research
Are you implementation ready? An alternative patient and healthcare system-centered model for pharma
- 12 Aug 2026
- Journal of Comparative Effectiveness Research
Identification of treatment effect modifiers and prognostic factors in newly diagnosed and relapsed or refractory multiple myeloma.
- 12 Aug 2026
- Journal of comparative effectiveness research
Iron deficiency treatment pathway in Italy: patients' perceptions of diagnosis and treatment.
- 28 Nov 2025
- Journal of comparative effectiveness research
Comparison treatments for basal ganglia hemorrhage: minimally invasive puncture and drainage versus craniotomy versus conservative treatment.
- 27 Nov 2025
- Journal of comparative effectiveness research
Adherence, treatment utilization, clinical and economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US.
- 24 Nov 2025
- Journal of comparative effectiveness research
Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan.
- 20 Nov 2025
- Journal of comparative effectiveness research
Are you implementation ready? An alternative patient and healthcare system-centered model for pharma
- 12 Aug 2026
- Journal of Comparative Effectiveness Research
Identification of treatment effect modifiers and prognostic factors in newly diagnosed and relapsed or refractory multiple myeloma.
- 12 Aug 2026
- Journal of comparative effectiveness research
Iron deficiency treatment pathway in Italy: patients' perceptions of diagnosis and treatment.
- 28 Nov 2025
- Journal of comparative effectiveness research
Comparison treatments for basal ganglia hemorrhage: minimally invasive puncture and drainage versus craniotomy versus conservative treatment.
- 27 Nov 2025
- Journal of comparative effectiveness research
Adherence, treatment utilization, clinical and economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US.
- 24 Nov 2025
- Journal of comparative effectiveness research
Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan.
- 20 Nov 2025
- Journal of comparative effectiveness research